| PHUSE US |
2026 |
Submitting RWD: Where We Are and Where We Are Going |
Ingeborg Holt,
Jeffrey M. Abolafia |
source
presentation source |
24 |
| PHUSE EU |
2025 |
Close Encounters with Real-World Data |
Jeffrey M. Abolafia,
Ingeborg Holt |
source
presentation source |
21 |
| PHUSE US |
2025 |
Considerations for the Submission of RWD using CDISC with Insights from HL7 FHIR and OMOP |
Ingeborg Holt,
Jeffrey M. Abolafia |
source
presentation source |
15 |
| PHUSE EU |
2024 |
Considerations for the Submission of RWD using CDISC with Insights from HL7 FHIR and OMOP |
Jeffrey M. Abolafia,
Ingeborg Holt |
source
presentation source |
13 |
| PHUSE US |
2024 |
Data Quality Evaluation of EHR FHIR API Real-World Data for FDA and Pharmaceutical Industry Use for Analysis and AI Implementation |
Abhishek Pandey,
Matthew Deady,
Brian Goodness |
source
presentation source |
10 |
| PHUSE US |
2024 |
Future Clinical Data Submission Standards: CDISC, FHIR, OMOP, or Hybrid Model |
Jeffrey M. Abolafia,
Ingeborg Holt |
source
presentation source |
10 |
| PHUSE EU |
2023 |
Submission Standards for Real-World Data: Gaps, Limitations and Recommendations |
Jeffrey M. Abolafia,
Ingeborg Holt |
source
presentation source |
8 |
| PHUSE US |
2023 |
Challenges and Considerations for Submitting Real World Data [presentation] |
Ingeborg Holt,
Jeffrey M. Abolafia |
source |
33 |
| PHUSE EU |
2022 |
Submission Standards for RWD: The Good, the Bad and the Ugly [presentation] |
Jeffrey M. Abolafia,
Ingeborg Holt |
source
video |
33 |
HOME
QUICK SEARCH
AUTHORS
KEYWORDS
HELP
BUGS